Signaling and Chromatin Networks in Cancer Biology

Elisabeth Hessmann, Raul Urrutia, Alexander Koenig

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In addition to diseases related to the cardiovascular system, cancer remains the most common morbidity in the developed world. Despite huge efforts by researchers, clinicians, and the industry, effective therapeutic targeting of malignancies remains challenging. Among the many features that characterize cancer cells, their ability to undergo dynamic and reversible transitions between multiple phenotypic states in adaptation to external signals represents the major hurdle in cancer therapy. This plasticity represents a powerful cellular program that enables cancer cells to naturally select for advantageous traits to circumvent cellular checkpoints and to evade cancer therapy. On the molecular level, cellular plasticity is controlled by several highly interconnected signaling pathways, which integrate extracellular signals of the tumor environment to a small cohort of transcription factors. These regulators control complex epigenetic mechanisms, such as modifications of chromatin-associated histones, to achieve widespread changes in gene expression required for the plastic phenotype of cancer cells. This chapter will summarize the most relevant molecular events that underlie and control cancer cell plasticity and illuminate how the understanding of these functional networks might impact cancer progression, therapy, and prognosis.

Original languageEnglish (US)
Title of host publicationChromatin Signaling and Diseases
PublisherElsevier Inc.
Pages241-253
Number of pages13
ISBN (Electronic)9780128026090
ISBN (Print)9780128023891
DOIs
StatePublished - Aug 24 2016

Fingerprint

Chromatin
Cells
Plasticity
Neoplasms
Cardiovascular system
Gene expression
Histones
Tumors
Transcription Factors
Plastics
Industry
Therapeutics
Cardiovascular System
Epigenomics
Research Personnel
Morbidity
Phenotype
Gene Expression

Keywords

  • Cancer cell plasticity
  • Chromatin modifications
  • EMT
  • Pancreatic cancer
  • Transcription

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Hessmann, E., Urrutia, R., & Koenig, A. (2016). Signaling and Chromatin Networks in Cancer Biology. In Chromatin Signaling and Diseases (pp. 241-253). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-802389-1.00013-7

Signaling and Chromatin Networks in Cancer Biology. / Hessmann, Elisabeth; Urrutia, Raul; Koenig, Alexander.

Chromatin Signaling and Diseases. Elsevier Inc., 2016. p. 241-253.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hessmann, E, Urrutia, R & Koenig, A 2016, Signaling and Chromatin Networks in Cancer Biology. in Chromatin Signaling and Diseases. Elsevier Inc., pp. 241-253. https://doi.org/10.1016/B978-0-12-802389-1.00013-7
Hessmann E, Urrutia R, Koenig A. Signaling and Chromatin Networks in Cancer Biology. In Chromatin Signaling and Diseases. Elsevier Inc. 2016. p. 241-253 https://doi.org/10.1016/B978-0-12-802389-1.00013-7
Hessmann, Elisabeth ; Urrutia, Raul ; Koenig, Alexander. / Signaling and Chromatin Networks in Cancer Biology. Chromatin Signaling and Diseases. Elsevier Inc., 2016. pp. 241-253
@inbook{43219a3d19d64840b8f4bc2739cee65d,
title = "Signaling and Chromatin Networks in Cancer Biology",
abstract = "In addition to diseases related to the cardiovascular system, cancer remains the most common morbidity in the developed world. Despite huge efforts by researchers, clinicians, and the industry, effective therapeutic targeting of malignancies remains challenging. Among the many features that characterize cancer cells, their ability to undergo dynamic and reversible transitions between multiple phenotypic states in adaptation to external signals represents the major hurdle in cancer therapy. This plasticity represents a powerful cellular program that enables cancer cells to naturally select for advantageous traits to circumvent cellular checkpoints and to evade cancer therapy. On the molecular level, cellular plasticity is controlled by several highly interconnected signaling pathways, which integrate extracellular signals of the tumor environment to a small cohort of transcription factors. These regulators control complex epigenetic mechanisms, such as modifications of chromatin-associated histones, to achieve widespread changes in gene expression required for the plastic phenotype of cancer cells. This chapter will summarize the most relevant molecular events that underlie and control cancer cell plasticity and illuminate how the understanding of these functional networks might impact cancer progression, therapy, and prognosis.",
keywords = "Cancer cell plasticity, Chromatin modifications, EMT, Pancreatic cancer, Transcription",
author = "Elisabeth Hessmann and Raul Urrutia and Alexander Koenig",
year = "2016",
month = "8",
day = "24",
doi = "10.1016/B978-0-12-802389-1.00013-7",
language = "English (US)",
isbn = "9780128023891",
pages = "241--253",
booktitle = "Chromatin Signaling and Diseases",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Signaling and Chromatin Networks in Cancer Biology

AU - Hessmann, Elisabeth

AU - Urrutia, Raul

AU - Koenig, Alexander

PY - 2016/8/24

Y1 - 2016/8/24

N2 - In addition to diseases related to the cardiovascular system, cancer remains the most common morbidity in the developed world. Despite huge efforts by researchers, clinicians, and the industry, effective therapeutic targeting of malignancies remains challenging. Among the many features that characterize cancer cells, their ability to undergo dynamic and reversible transitions between multiple phenotypic states in adaptation to external signals represents the major hurdle in cancer therapy. This plasticity represents a powerful cellular program that enables cancer cells to naturally select for advantageous traits to circumvent cellular checkpoints and to evade cancer therapy. On the molecular level, cellular plasticity is controlled by several highly interconnected signaling pathways, which integrate extracellular signals of the tumor environment to a small cohort of transcription factors. These regulators control complex epigenetic mechanisms, such as modifications of chromatin-associated histones, to achieve widespread changes in gene expression required for the plastic phenotype of cancer cells. This chapter will summarize the most relevant molecular events that underlie and control cancer cell plasticity and illuminate how the understanding of these functional networks might impact cancer progression, therapy, and prognosis.

AB - In addition to diseases related to the cardiovascular system, cancer remains the most common morbidity in the developed world. Despite huge efforts by researchers, clinicians, and the industry, effective therapeutic targeting of malignancies remains challenging. Among the many features that characterize cancer cells, their ability to undergo dynamic and reversible transitions between multiple phenotypic states in adaptation to external signals represents the major hurdle in cancer therapy. This plasticity represents a powerful cellular program that enables cancer cells to naturally select for advantageous traits to circumvent cellular checkpoints and to evade cancer therapy. On the molecular level, cellular plasticity is controlled by several highly interconnected signaling pathways, which integrate extracellular signals of the tumor environment to a small cohort of transcription factors. These regulators control complex epigenetic mechanisms, such as modifications of chromatin-associated histones, to achieve widespread changes in gene expression required for the plastic phenotype of cancer cells. This chapter will summarize the most relevant molecular events that underlie and control cancer cell plasticity and illuminate how the understanding of these functional networks might impact cancer progression, therapy, and prognosis.

KW - Cancer cell plasticity

KW - Chromatin modifications

KW - EMT

KW - Pancreatic cancer

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=85018796381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018796381&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-802389-1.00013-7

DO - 10.1016/B978-0-12-802389-1.00013-7

M3 - Chapter

SN - 9780128023891

SP - 241

EP - 253

BT - Chromatin Signaling and Diseases

PB - Elsevier Inc.

ER -